News & views

The company is launching its first consumer product, BloomCalma™, a microbiome-friendly intimate moisturiser.

The seed funding will help develop technology to extract more information from tissue slides.

Orphan therapy has another chance to reach children with urea cycle disorder, OTCD.

UCL has once again been recognised as one of the UK's leading universities for 'knowledge exchange'.

From surgery to data centres, UCL Ventures’ spinouts are using AI to transform lives.

Investment will accelerate the translation of world-leading ophthalmology research into clinical practice.

UCL spinout’s acoustic emission sensing and AI technology could reduce battery manufacturing time by 30%.

First patient trial uses soundwaves to reach deep brain structures without surgery or implants.

Dr Anne Lane has spoken about university commercialisation as CEO of UCL's expert commercialisation partner.

UCL spinout, Trace Neuroscience, reaches a major milestone: in-human trials.

A UCL Ventures spinout is opening up the World Cup experience to more people, using accessible technology.

Academic-turned-founder Dr. Martin Pule spoke about the realities and rewards taking cancer therapies to market at I-O Converse.